SYRS - Syros Pharmaceuticals GAAP EPS of -$0.59 beats by $0.18
2024-07-31 07:32:02 ET
More on Syros Pharmaceuticals
- Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout
- Syros Pharmaceuticals, Inc. (SYRS) Q1 2024 Earnings Call Transcript
- Syros Pharmaceuticals Q2 2024 Earnings Preview
- Syros Pharmaceuticals GAAP EPS of -$0.10 beats by $0.77
- Seeking Alpha’s Quant Rating on Syros Pharmaceuticals